Technical Analysis for ABCL - AbCellera Biologics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 10.42 | -3.61% | -0.39 |
ABCL closed down 3.61 percent on Wednesday, February 8, 2023, on 71 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: Feb 21
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Fell Below 200 DMA | Bearish | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| 50 DMA Support | Bullish | -3.61% | |
| Bollinger Band Squeeze | Range Contraction | -3.61% | |
| BB Squeeze Started | Range Contraction | -3.61% | |
| Overbought Stochastic | Strength | -3.61% | |
| Stochastic Sell Signal | Bearish | -5.01% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 20 DMA Support | about 9 hours ago |
| 200 DMA Support | about 9 hours ago |
| Fell Below 200 DMA | about 9 hours ago |
| Down 3% | about 9 hours ago |
| Fell Below 20 DMA | about 9 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/21/2023
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Health Sciences Pharmacy Antibodies Medication Drug Development Pharmacology Pharmaceutical Sciences
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Health Sciences Pharmacy Antibodies Medication Drug Development Pharmacology Pharmaceutical Sciences
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.97 |
| 52 Week Low | 5.42 |
| Average Volume | 1,829,894 |
| 200-Day Moving Average | 10.43 |
| 50-Day Moving Average | 10.62 |
| 20-Day Moving Average | 10.49 |
| 10-Day Moving Average | 10.74 |
| Average True Range | 0.49 |
| RSI | 47.92 |
| ADX | 14.33 |
| +DI | 21.93 |
| -DI | 20.56 |
| Chandelier Exit (Long, 3 ATRs) | 9.89 |
| Chandelier Exit (Short, 3 ATRs) | 10.64 |
| Upper Bollinger Bands | 11.19 |
| Lower Bollinger Band | 9.78 |
| Percent B (%b) | 0.45 |
| BandWidth | 13.54 |
| MACD Line | 0.10 |
| MACD Signal Line | 0.04 |
| MACD Histogram | 0.061 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.34 | ||||
| Resistance 3 (R3) | 11.42 | 11.19 | 11.18 | ||
| Resistance 2 (R2) | 11.19 | 10.96 | 11.15 | 11.13 | |
| Resistance 1 (R1) | 10.81 | 10.82 | 10.70 | 10.73 | 11.08 |
| Pivot Point | 10.58 | 10.58 | 10.53 | 10.54 | 10.58 |
| Support 1 (S1) | 10.20 | 10.35 | 10.09 | 10.12 | 9.76 |
| Support 2 (S2) | 9.97 | 10.21 | 9.93 | 9.71 | |
| Support 3 (S3) | 9.59 | 9.97 | 9.66 | ||
| Support 4 (S4) | 9.51 |
